Weekly Chest CasesImaging Conference Cases

Case No : 4

Add to Favorites

  • Age/Sex 44 / F
  • Case Title Atrial fibrillation (+) Mitral valve replacement due to mitral stenosis 9 years ago.
  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4

Diagnosis With Brief Discussion

Courtesy
K
Past History
Amiodarone treatment
1997.10 ~ 1999.2
2000.1 ~ 2005.7 600mg /day
Reviewy
Amiodarone hydrochloride (Cordarone¢c)

Effective antiarrhythmic drug
Benzofuran derivatives (thyroxine) : iodine content
Accumulate in the liver and lung(half-life is extremely long:15-60 ds)
Adverse effect: corneal microdeposit, grey-blue skin discoloration,
pph. neuropathy, weakness, nausea, bradycardia, hypo- or hyperthyroidism



Pulmonary toxicity : most severe Cx

Incidence : 5-10%
Mortality rate : 10-20%
Daily dose > 600~800 mg (No correlation with total accumulative dose)
Occur between 6 days to 60 months (Highest incidence during the first 12 months)


Clinical presentation

Dyspnea, cough and even to ARDS


Radiographic findings

Nonspecific
Consolidation, infiltration, interstitial disease
NSIP: most common manifestation
BOOP: less common
Pleural effusion: pleural inflammation


CT findings

High-attenuation area of peripheral consolidation: Foamy macrophages in the interstitium and alveolar space
Also seen in liver and spleen
Reticular opacities or GGO


Treatment

Stop amiodarone
Corticosteroid


Prognosis

Good, improving after discontinuation


Resolution of abnormal radiologic findings

After 2-12 months
Do not correlate with clinical improvemen
Keywords
Lung, Interstitial lung disease, Drug induced pulmonary toxicity,
  • Top
  • Back

Each Case of This Site Supplied by the Members of KSTR.
Copyright of the Images is in the KSTR and Original Supplier.
Current Editor : Sang Young Oh, M.D., Ph.D Email : sangyoung.oh@gmail.com

This website is optimized for IE 10 and above.